1-3 of 3
Paul J. Chiao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mechanisms of Overcoming Intrinsic Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma through the Redox Modulation

Huai-Qiang Ju, Takeshi Gocho, Mitzi Aguilar, Min Wu, Zhuo-Nan Zhuang, Jie Fu, Katsuhiko Yanaga, Peng Huang, Paul J. Chiao
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (3): 788–798.
https://doi.org/10.1158/1535-7163.MCT-14-0420
Published: 09 March 2015
View articletitled, Mechanisms of Overcoming Intrinsic Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma through the Redox Modulation
Open the PDF for Mechanisms of Overcoming Intrinsic Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma through the Redox Modulation in another window
Includes: Supplementary data
Journal Articles

LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis

Davide Melisi, Satoshi Ishiyama, Guido M. Sclabas, Jason B. Fleming, Qianghua Xia, Giampaolo Tortora, James L. Abbruzzese, Paul J. Chiao
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (4): 829–840.
https://doi.org/10.1158/1535-7163.MCT-07-0337
Published: 15 April 2008
View articletitled, LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
Open the PDF for LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis in another window
Includes: Supplementary data
Journal Articles

Inhibition of constitutively activated nuclear factor-κB radiosensitizes human melanoma cells

Anupama Munshi, John F. Kurland, Takashi Nishikawa, Paul J. Chiao, Michael Andreeff, Raymond E. Meyn
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2004) 3 (8): 985–992.
https://doi.org/10.1158/1535-7163.985.3.8
Published: 01 August 2004
View articletitled, Inhibition of constitutively activated nuclear factor-κB radiosensitizes human melanoma cells
Open the PDF for Inhibition of constitutively activated nuclear factor-κB radiosensitizes human melanoma cells in another window